New Delhi, March 10 -- India's drugmakers saw healthy revenue growth across all therapies in February as they debuted new drugs and raised prices, an industry report showed.

Sales in the domestic pharmaceutical market in February touched Rs.18,781 crore, up 7.5% from a year earlier, data from B2B commerce platform Pharmarack showed. Overall, the moving annual total (MAT) value growth until February was 8.1%, with the industry clocking sales of Rs.2.24 trillion. MAT refers to the total value of sales over the previous 12 months.

However, volumes fell 0.2% in February."Volume growth overall for the market seems to be stagnated," said Sheetal Sapale, vice-president, commercial at Pharmarack. This is in keeping with previous months, where m...